Oral Semaglutide Sublngual Drops

BUY Oral Semaglutide Sublngual Drops

Oral Semaglutide Sublingual Drops are a needle-free, compounded medication for type 2 diabetes management and off-label weight loss. Unlike injectable semaglutide (Ozempic, Wegovy) or oral tablets (Rybelsus), these drops are placed under the tongue for absorption via the salivary glands, offering convenience for those avoiding injections. Compounded by pharmacies like Strive or Carie Boyd, they’re not FDA-approved but prescribed based on patient needs.

Mechanisms of Action
Semaglutide, a GLP-1 receptor agonist, mimics the incretin hormone, stimulating insulin release during high blood glucose, slowing gastric emptying, and suppressing appetite. Sublingual delivery bypasses the digestive system, leveraging the sublingual mucosa’s blood vessels for faster absorption. Preclinical data suggests comparable pharmacokinetics to FDA-approved GLP-1s, with animal studies showing effective glucose control and weight loss.

Potential Benefits

Weight Loss: Achieves 10–15% body weight loss over 6–12 months with lifestyle changes, though less potent than injectables (15–20%).

Blood Sugar Control: Lowers HbA1c by 0.8–1.5% in type 2 diabetes patients.

Convenience: Daily sublingual dosing eliminates needles, ideal for needle-averse patients.

Reduced Side Effects: May cause less nausea than injections due to lower systemic peaks.
Users report appetite suppression and weight loss within 4–8 weeks.

Usage and Administration
Typical titration: 0.25 mL (0.5–1 mg) daily under the tongue for 30 days, increasing to 0.5 mL, then 0.75 mL as needed, held for 1–2 minutes before swallowing. Take on an empty stomach, 30 minutes before food or other medications, with minimal water. Shake the bottle gently before use. Store at 36–46°F.

Safety and Side Effects
Common side effects include nausea, diarrhea, and stomach pain (10–20% of users), often subsiding within weeks. Rare risks include pancreatitis or allergic reactions. Not suitable for those with medullary thyroid carcinoma, MEN2, or during pregnancy/breastfeeding. Not FDA-approved; long-term data is limited. Consult a provider if side effects persist.

Legal Status
Available by prescription from compounding pharmacies. Not FDA-approved; banned by WADA. Purchase from reputable sources like Carie Boyd or Henry Meds.